Actively Recruiting
Evaluating Attention Bias Modification Compared to Placebo Training for Adults with Social Anxiety Disorder to Reduce Symptoms
Led by Tel Aviv University · Updated on 2026-06-24
90
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a computerized attention-training method called attention bias modification ABM to see if it can reduce symptoms of social anxiety disorder SAD in adults. The study also explores whether improvements in symptoms are due to changes in how attention is processed or to other factors like placebo effects and expectations. Social Anxiety Disorder involves a persistent fear of social situations and negative judgment, often linked to focusing on threatening social cues such as angry faces. Participants diagnosed with SAD will be randomly assigned to one of three groups active ABM training, placebo training, or a wait-list control group. The active ABM involves eight computerized sessions over four weeks where attention is trained away from threatening faces. The placebo group completes similar sessions without emotional or attentional training elements. The wait-list group undergoes assessments without intervention. The study is designed to clarify the specific effects of ABM compared to nonspecific factors. During the study, participants will complete clinical interviews, questionnaires, and computerized tasks before and after the intervention to assess social anxiety symptoms and attention biases. Eye-tracking and reaction-time measures will evaluate changes in attentional processing. Treatment expectancy and credibility will also be recorded. The main outcome is the change in social anxiety symptoms over about six weeks. Additional measures include changes in anxiety, depressive symptoms, and attention variability, with follow-up assessments approximately two weeks after treatment ends.
CONDITIONS
Brief Title
Efficacy of Attention Bias Modification vs. Placebo for Social Anxiety Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18-65 years
- Primary diagnosis of generalized Social Anxiety Disorder confirmed by clinical evaluation and MINI interview
- Liebowitz Social Anxiety Scale (LSAS) score greater than 50
- Normal or corrected-to-normal vision without color blindness
- Adequate Hebrew proficiency to complete interviews and questionnaires
You will not qualify if you...
- Prior participation in attention bias modification training using a dot-probe task
- Prior eye-tracking-based attention training
- Current diagnosis of Post-Traumatic Stress Disorder
- Current or past psychotic disorder or bipolar disorder
- Neurological disorders such as epilepsy or traumatic brain injury
- Severe suicidal thoughts
- Current substance or alcohol use disorder
- Receiving pharmacological or psychosocial treatment unless stable for at least 45 days
- Pregnancy
- Uncorrected visual impairment or use of multifocal glasses
Research Team
Y
Yair Bar-Haim, PhD
L
Lital Kohn, MA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here